BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28396161)

  • 1. Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
    Shem-Tov N; Saraceni F; Danylesko I; Shouval R; Yerushalmi R; Nagler A; Shimoni A
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1087-1094. PubMed ID: 28396161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Gavriilaki M; Apostolou C; Iskas M; Voutiadou G; Bouziana S; Bousiou Z; Constantinou V; Masmanidou M; Sotiropoulos D; Yannaki E; Lalayanni C; Pilavaki M; Chatziioannou K; Papayannopoulos S; Anagnostopoulos A
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1756-1760. PubMed ID: 31128329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia.
    Hazar V; Öztürk G; Yalçın K; Uygun V; Aksoylar S; Küpesiz A; Ok Bozkaya İ; Karagün BŞ; Bozkurt C; İleri T; Atay D; Koçak Ü; Karasu GT; Yeşilipek A; Gökçe M; Kansoy S; Kintrup GT; Karakükcü M; Okur FV; Ertem M; Kaya Z; Gürsel O; Yaman Y; Özbek N; Antmen B; Tüfekçi Ö; Albayrak C; Adaklı Aksoy B; Sezgin G; Albayrak D; Evim MS; Zengin E; Pekpak E;
    Transplant Cell Ther; 2021 Oct; 27(10):859.e1-859.e10. PubMed ID: 34216791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population.
    Arias-Espinosa L; Acosta-Medina AA; Vargas-España A; Fuentes-Martin V; Colunga-Pedraza PR; Hawing-Zarate JA; Leon AG; Soto-Mota A; Pacheco-Gutierrez G; Vargas-Serafín C; Barrera-Lumbreras G; Bourlon C
    Transplant Cell Ther; 2023 Aug; 29(8):510.e1-510.e9. PubMed ID: 37169289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated Extramedullary Relapse After Human Leukocyte Antigen-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Case Reports and Literature Review.
    Khemaphiphat P; Wudhikarn K; Bunworasate U; Chanswangphuwana C
    Transplant Proc; 2021; 53(6):2029-2034. PubMed ID: 33962773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yuda S; Fuji S; Onishi A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1152-1157. PubMed ID: 30660773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Harris AC; Kitko CL; Couriel DR; Braun TM; Choi SW; Magenau J; Mineishi S; Pawarode A; Yanik G; Levine JE
    Haematologica; 2013 Feb; 98(2):179-84. PubMed ID: 23065502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation.
    Shimoni A; Labopin M; Savani B; Volin L; Ehninger G; Kuball J; Bunjes D; Schaap N; Vigouroux S; Bacigalupo A; Veelken H; Sierra J; Eder M; Niederwieser D; Mohty M; Nagler A
    J Hematol Oncol; 2016 Nov; 9(1):118. PubMed ID: 27821187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.
    Solh M; DeFor TE; Weisdorf DJ; Kaufman DS
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
    Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?
    Riviello-Goya S; Acosta-Medina AA; Inclan-Alarcon SI; Garcia-Miranda S; Bourlon C
    Oncology (Williston Park); 2020 Feb; 34(2):39-43. PubMed ID: 32645192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
    Savani BN; Labopin M; Kröger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socié G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Jun; 101(6):773-80. PubMed ID: 26969081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature.
    Potenza L; Luppi M; Riva G; Morselli M; Ferrari A; Imovilli A; Giacobbi F; Temperani P; Donelli A; Narni F; Torelli G
    Am J Hematol; 2006 Jan; 81(1):45-50. PubMed ID: 16369953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.